CA2127532A1 - Anticorps reconnaissant le quatrieme domaine similaire a l'immunoglobuline de vcam1 - Google Patents

Anticorps reconnaissant le quatrieme domaine similaire a l'immunoglobuline de vcam1

Info

Publication number
CA2127532A1
CA2127532A1 CA002127532A CA2127532A CA2127532A1 CA 2127532 A1 CA2127532 A1 CA 2127532A1 CA 002127532 A CA002127532 A CA 002127532A CA 2127532 A CA2127532 A CA 2127532A CA 2127532 A1 CA2127532 A1 CA 2127532A1
Authority
CA
Canada
Prior art keywords
leu
ser
glu
val
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002127532A
Other languages
English (en)
Inventor
Laurelee Osborn
Christopher D. Benjamin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2127532A1 publication Critical patent/CA2127532A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002127532A 1992-01-13 1993-01-12 Anticorps reconnaissant le quatrieme domaine similaire a l'immunoglobuline de vcam1 Abandoned CA2127532A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82171292A 1992-01-13 1992-01-13
US821,712 1992-01-13

Publications (1)

Publication Number Publication Date
CA2127532A1 true CA2127532A1 (fr) 1993-07-22

Family

ID=25234110

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002127532A Abandoned CA2127532A1 (fr) 1992-01-13 1993-01-12 Anticorps reconnaissant le quatrieme domaine similaire a l'immunoglobuline de vcam1

Country Status (5)

Country Link
EP (1) EP0623173A1 (fr)
JP (1) JPH07506244A (fr)
AU (1) AU664071B2 (fr)
CA (1) CA2127532A1 (fr)
WO (1) WO1993014220A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2021373A4 (fr) * 2006-05-31 2010-06-02 Hanwa Chemical Corp Anticorps monoclonal vcam-1 spécifique
KR101238061B1 (ko) * 2009-03-31 2013-02-27 한화케미칼 주식회사 Ｖｃａｍ－１에 특이적으로 결합하는 인간 단일클론항체 및 그를 포함하는 염증성 질환 또는 암의 치료용 조성물
GB201207155D0 (en) 2012-04-24 2012-06-06 Isis Innovation Antibodies
US10947311B2 (en) 2015-11-20 2021-03-16 The Board Of Trustees Of The Leland Stanford Junior University VCAM-1 mediated methods and compositions for treating aging-associated impairments
US11560433B2 (en) 2016-05-27 2023-01-24 Albert Einstein College Of Medicine Methods of treatment by targeting VCAM1 and MAEA
WO2017205560A1 (fr) * 2016-05-27 2017-11-30 Albert Einstein College Of Medicine, Inc. Méthodes de traitement du cancer par ciblage de vcam1 et de maea

Also Published As

Publication number Publication date
EP0623173A1 (fr) 1994-11-09
JPH07506244A (ja) 1995-07-13
AU664071B2 (en) 1995-11-02
AU3431893A (en) 1993-08-03
WO1993014220A1 (fr) 1993-07-22

Similar Documents

Publication Publication Date Title
US5484892A (en) Monoclonal antibodies that block ligand binding to the CD22 receptor in mature B cells
EP0458911B1 (fr) Molecules d'adhesion leucocytes-cellules endotheliales (elam) et molecules impliquees dans l'adhesion des leucocytes (mila)
US5766947A (en) Monoclonal antibodies reactive with an epitope of a Vβ3.1 variable region of a T cell receptor
KR100297082B1 (ko) 인체 Ｔ 임파구 수용체의 β 사슬의 가변성 영역을 코딩하는 뉴클레오티드 서열, 대응하는 펩티드 세그먼트 및 진단 및 치료 용도
CA2132091C (fr) Anticorps diriges contre l'integrine alphavbeta3
EP0555880A2 (fr) Récepteur CD40CR et ses ligands
US5445940A (en) Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease
JPH09511644A (ja) プロテインチロシンキナーゼアゴニスト抗体
AU685745B2 (en) Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily
WO1995029693A1 (fr) Methodes et compositions permettant de moduler les interactions heterotypiques entre la e-cadherine et des lymphocytes t
US20030153731A1 (en) Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
WO1992000751A1 (fr) Composition pharmaceutique comprenant une molecule d'adherence cellulaire
US5599676A (en) Method for isolating a novel receptor for α4 integrins
CA2127532A1 (fr) Anticorps reconnaissant le quatrieme domaine similaire a l'immunoglobuline de vcam1
CA2190262A1 (fr) Anticorps monoclonal specifique d'un antigene endoglyx-1 de cellules endotheliales vasculaires, l'antigene lui-meme et ses utilisations
WO1991013085A1 (fr) Molecule d'adherance endotheliale a orientation leucocytaire mononucleaire associee a l'atherosclerose
Teixeira Structural analysis of the biliary glycoprotein (BGP) binding site
CA2005121A1 (fr) Reactif d'anticorps monoclonaux avec des regions definies des recepteurs d'antigenes des cellules t

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead